Key result
Presentation during the COVID-19 era did not alter the rate of long-term major cardiovascular and cerebrovascular events in STEMI patients compared to the pre-COVID-19 era.
Why the study?
The study aimed to compare MACCE rates between STEMI patients in the pre-COVID-19 and COVID-19 eras, and evaluate the impact of COVID-19 infection on long-term outcomes in Turkey.
Does presentation during the COVID-19 era or concurrent COVID-19 infection increase long-term MACCE in patients with STEMI?
Observational (n=1,748)
Yes
Does presentation during the COVID-19 era or concurrent COVID-19 infection increase long-term MACCE in patients with STEMI?
Answers are grounded in this paper and cite their sources.
While presentation during the COVID-19 era itself did not increase long-term MACCE in STEMI patients compared to the pre-COVID-19 era, concurrent COVID-19 infection significantly increased the risk of MACCE and heart failure hospitalization.
AIMS: To compare major cardiovascular and cerebrovascular events (MACCE) rates between patients in the pre-COVID-19 era and COVID-19 era, and to assess the impact of the presence of COVID-19 (+) on long-term MACCE in ST-segment elevation myocardial infarction (STEMI) in Turkey. METHODS: Using the TURSER study (TURKISH ST-segment elevation myocardial infarction registry) data, the current study included 1748 STEMI patients from 15 centres in Turkey. Patients were stratified into COVID-19 era (March 11st-May 15st, 2020; n = 723) or pre-COVID-19 era (March 11st-May 15st, 2019; n = 1025) cohorts. Long-term MACCE rates were compared between groups. In addition, the effect of COVID-19 positivity on long-term outcomes was evaluated. The primary outcome was the occurrence of MACCE at long-term follow-up, and the secondary outcome was hospitalization with heart failure. RESULTS: The MACCE and hospitalization with heart failure rates between pre-COVID-19 era and COVID-19 era were 23% versus 22% (p = .841), and 12% versus 8% (p = .002), respectively. In the COVID-19 era, the rates of MACCE and hospitalization with heart failure COVID-19-positive versus COVID-19-negative patients were 40% versus 20%, (p < .001), and 43% versus 11% (p < .001), respectively. CONCLUSION: There was no difference between the pre-COVID-19 era and the COVID-19 era in terms of MACCE in STEMI patients in Turkey. In the COVID-19 era, STEMI patients positive for COVID-19 had a higher rate of MACCE and heart failure hospitalization at the long-term follow-up.
No takes yet. Share an insight, caveat, or question.
Kırış et al. (2022) conducted an observational in ST-segment elevation myocardial infarction (STEMI) (n=1,748). COVID-19 era vs. pre-COVID-19 era was evaluated on Major cardiovascular and cerebrovascular events (MACCE) (p=0.841). Presentation during the COVID-19 era did not alter the rate of long-term major cardiovascular and cerebrovascular events in STEMI patients compared to the pre-COVID-19 era.
Synapse has enriched 10 related papers. Consider them for comparative context: